A recent report published in the medical journal Stem Cell Reports, sheds light on breakthrough research regarding the use of thyroid cells derived from stem cells for new therapies. Scientists at Boston University’s School Medicine led the work.
They have pinpointed a means of efficiently engineering thyroid cells by way of stem cells that will eventually help analyze and treat thyroid diseases (…)
The breakthrough described above was discovered after studies were performed on mice. Stem cells are valued as they can mature into an array of different cell types.
Researchers have developed a new line of genetically modified pigs that do not reject transplants, an advance that allows for future research on stem cell therapies.
One of the biggest challenges for medical researchers studying the effectiveness of stem cell therapies is that transplants or grafts of cells are often rejected by the hosts.
This rejection can render experiments useless, making research into potentially life-saving treatments a long and difficult process.
Now, researchers at the University of Missouri have shown that a new line of genetically modified pigs will host transplanted cells without the risk of rejection.
“The rejection of transplants and grafts